Document:

<PAGE>

                                                                   Exhibit 10.22

                        CONTRACT MANUFACTURING AGREEMENT

     This Contract Manufacturing Agreement (this "Agreement") is entered into as
of March 31, 2001, between Millipore Corporation ("Millipore"), a Massachusetts
corporation with its principal place of business at 80 Ashby Road, Bedford, MA
01730, and Mykrolis Corporation ("Mykrolis"), a Delaware corporation with its
principal place of business at Patriots Park, Bedford, MA 01730.

                                    RECITALS

     1.   Millipore currently owns all of the issued and outstanding common
stock of Mykrolis.

     2.   Millipore and Mykrolis have entered into a Master Separation and
Distribution Agreement as of March 28, 2001 (the "Master Agreement") under
which, among other things, the business of Millipore's Microelectronics Division
is to be taken over by, and the assets and liabilities associated therewith are
to be transferred to and assumed by, Mykrolis at the Separation Date (as defined
in the Master Agreement).

     3.   After the Separation Date, in order to enable Millipore to carry on
its respective business as a separate company, Millipore wishes that Mykrolis,
on a contract manufacturing basis, supply the product (or products) listed on
Exhibit A (the "Product") to Millipore, and Mykrolis wishes to do so.

     4.   The Master Agreement provides for this Agreement to be entered into as
of the Separation Date.

     NOW, THEREFORE, in consideration of the foregoing and the covenants and
agreements set forth below, the parties hereto agree as follows:

1.   Definitions.  Capitalized terms defined in this Agreement shall have the
     -----------
respective meanings assigned to them at the location of their definition.
Capitalized Terms used in this Agreement without definition which are defined in
the Master Agreement shall have the meaning ascribed thereto in the Master
Agreement.

2.   Overriding Character of this Agreement
     --------------------------------------

     A.   Unless otherwise agreed by both parties in writing, this Agreement
          applies to all purchase releases, purchase orders and other documents
          of purchase for the Products (hereinafter collectively referred to as
          "Releases") which Millipore may place with Mykrolis during the term of
          this Agreement.  The terms and conditions of this Agreement shall
          apply to any Releases, whether or not this Agreement or its terms and
          conditions are expressly referenced in the Release.
<PAGE>

     B.   Unless otherwise agreed by both parties in writing for a specific
          transaction, no inconsistent or additional term or condition in any
          Release shall be applicable to a transaction within the scope of this
          Agreement.  Both parties specifically agree that any term and
          condition on any of their purchase or sale documents used as Releases
          hereunder which are in any way inconsistent with this Agreement shall
          be inapplicable, and the terms of this Agreement shall govern.

3.   Supply of Product
     -----------------

     (a)  Mykrolis agrees to sell to Millipore, from time to time during the
          Term, Product, in the amounts contained in Millipore's Releases.
          Except as set forth in Section 6(a) hereof, Millipore shall have no
          minimum or maximum purchase requirements for the Products.

     (b)  Mykrolis agrees to manufacture and package the Products in accordance
          with the specifications therefor in effect as of the Separation Date.
          In addition, Mykrolis agrees to label and otherwise mark the Products
          and the packaging for the Products with Millipore's trademarks and
          trade names in accordance with artwork specified by Millipore.  Except
          as otherwise expressly agreed, Millipore agrees that it shall not
          resell the Products under any Mykrolis trademark or trade name.

4.   Term and Termination
     --------------------

     (a)  The effective period of this Agreement (the "Term") shall begin on the
          Separation Date and continue thereafter for a period of five (5) years
          or until earlier termination in accordance with clause (b) or (c) of
          this Section 4. Any Release issued by Millipore before the effective
          date of termination and in accordance with Section 6(a) hereof shall
          be fulfilled by Mykrolis.

     (b)  Either party may terminate this Agreement prior to the expiration of
          the Term without prejudice to any rights or liabilities accruing up to
          the date of termination:

          (i)  in the event of a material breach by the other party of any of
               the terms and conditions of this Agreement, by giving the other
               party notice of such breach, and provided that such breach shall
               not have been cured, or material steps to effect a cure
               undertaken within sixty (60) days following such notice; and

          (ii) immediately, by written notice thereof, if any of the following
               events or an event analogous thereto occurs:

                                       2
<PAGE>

               a.   an adjudication has been made that the other party is
                    bankrupt or insolvent;

               b.   the other party has filed bankruptcy proceedings or has had
                    such proceedings filed against it, except as part of a bona
                    fide scheme for reorganization;

               c.   a receiver has been appointed for all or substantially all
                    of the property of the other party;

               d.   the other party has assigned or attempted to assign this
                    Agreement for the benefit of its creditors; or

               e.   the other party has begun any proceeding for the liquidation
                    or winding up of its business affairs.

     (c)  Millipore may terminate this Agreement effective at any time, provided
          it has given Mykrolis at least sixty (60) days prior written notice
          thereof.

     (d)  Termination under this Section 4 shall be in addition to and not a
          substitute for other rights or causes of action of the terminating
          party.

5.   Price
     -----

     (a)  For the first year of this Agreement, the price shall be as set forth
          on Exhibit A, which is attached and incorporated by reference.
          Thereafter, Mykrolis shall be entitled to adjust prices annually on
          each anniversary of the Separation Date in order to recoup actual
          increases in the cost to manufacture the Products.  Mykrolis agrees to
          justify any price increases hereunder by an open-book review of its
          costs with Millipore.

     (b)  Prices and deliveries will be FOB the Mykrolis plant which is
          producing the Product.

6.   Orders, Delivery and Payment
     ----------------------------

     (a)  Millipore will provide Mykrolis with a rolling one year forecast of
          its demand for Product hereunder (a "One-Year Forecast") which will be
          updated on a quarterly basis, at least thirty (30) days prior to the
          start of each calendar quarter. Each such One-Year Forecast shall
          include a sub-forecast for the first three months within the One-Year
          Forecast (a "3 Month Forecast"). Millipore shall provide Releases for
          delivery, during the three months covered by such 3 Month Forecast, in
          the quantities specified therein, but subject to increase or reduction
          in such quantities of not more than 25%. Except for such purchase
          commitment in the 3 Month Forecasts, the One-Year Forecasts will be
          used for

                                       3
<PAGE>

          planning purposes only and are not binding. Mykrolis will ship Product
          so as to arrive on the delivery date set forth in a Release, provided
          that the delivery date set forth in such Release is not less than 30
          days following the date Mykrolis receives such Release and provided
          that the amounts set forth in such Release are within the range
          provided above in accordance with the applicable 3 Month Forecast.

     (b)  Millipore shall make payment to Mykrolis within forty-five (45) days
          after the later of (i) receipt of the Product, and (ii) receipt of
          Mykrolis's invoice for the Product. All payments shall be made in U.S.
          Dollars. Late payments shall bear interest at a rate of 12% per annum.

     (c)  All Product shall be tested, inspected and packaged for delivery by
          Mykrolis as mutually agreed by the parties.

     (d)  Mykrolis shall make reasonable best efforts to ship the Product in
          accordance with the requested delivery dates.  Mykrolis shall give
          prompt notice of any delay in shipment and shall use diligence to
          remove the cause of any such delay, provided, however, that Mykrolis
                                              --------  -------
          accepts no liability for general, special, or consequential damages
          arising out of delay in delivery.

     (e)  Identification of the Products to this Agreement shall occur when they
          are packed for shipment, addressed to Millipore and delivered to a
          common carrier, at which time title and risk of loss shall pass to
          Millipore.  In the event that any shipment of Products or any portion
          thereof fails to conform to the applicable specifications, then
          Millipore shall be entitled to reject such shipment of Products or the
          portion thereof that fails to so conform, as the case may be.
          Millipore shall communicate its rejection hereunder by written notice,
          given within twenty (20) days following the date on which such
          shipment was received by Millipore, specifying the grounds for such
          rejection.  If no written notice of rejection is given by Millipore
          within said twenty (20) day period, the Products shall be deemed to
          have been accepted, and to have conformed to the applicable
          specifications.  In the event of any proper and timely rejection,
          Mykrolis agrees:  (i) that it shall bear the cost of shipment for the
          return of rejected Products and (ii) to use its reasonable best
          efforts to cure such rejection or replace such nonconforming Products
          within thirty (30) days after receipt of written notice thereof.

7.   Warranties
     ----------

     Mykrolis Corporation ("Mykrolis") warrants the Products will be free from
     defects in materials and workmanship when used in accordance with the
     applicable instructions for a period of one year from shipment of the
     Products. Mykrolis MAKES NO OTHER WARRANTY, EXPRESSED OR IMPLIED. THERE IS
     NO

                                       4
<PAGE>

     WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. The
     warranty provided herein and the data, specifications and descriptions of
     Mykrolis products appearing in Mykrolis's published catalogues and product
     literature may not be altered except by express written agreement signed by
     an officer of Mykrolis. Representations, oral or written, which are
     inconsistent with this warranty or such publications are not authorized and
     if given, should not be relied upon.

     In the event of a breach of the foregoing warranty, Mykrolis's sole
     obligation shall be to repair or replace, at its option, the applicable
     Product or part thereof, provided Millipore notifies Mykrolis promptly of
     any such breach. If after exercising reasonable efforts, Mykrolis is unable
     to repair or replace the Product or part, then Mykrolis shall refund to
     Millipore all monies paid for such applicable product or part. Mykrolis
     SHALL NOT BE LIABLE FOR CONSEQUENTIAL, INCIDENTAL, SPECIAL OR ANY OTHER
     INDIRECT DAMAGES RESULTING FROM ECONOMIC LOSS OR PROPERTY DAMAGE SUSTAINED
     BY ANY CUSTOMER FROM THE USE OF ITS PRODUCTS.

8.   Product Modifications
     ---------------------

     Mykrolis agrees that it will not materially change the Product that it will
     supply hereunder or their formulation, manufacturing or testing processes,
     process equipment, other aspects of form, fit or function, or production
     location, unless Millipore approves such change in writing, which approval
     may require formal validation and qualification and possibly customer
     notification. The implementation of any such accepted changes shall be
     subject to the parties' agreement on any change in price or other terms of
     supply as may be necessitated or requested by a party as a result of such
     change.

9.   Inventory
     ---------

     Mykrolis will maintain an inventory of Product, in such amounts as shall be
     agreed by the parties but in no event less than amounts specified in
     Millipore's current 3 Month Forecast.

10.  Access to Facilities
     --------------------

     At any time during the Term, upon reasonable advance notice by Millipore,
     Millipore's authorized representatives and customers (subject to
     appropriate confidentiality obligations) shall be provided access to the
     facilities of Mykrolis to audit or verify conformity of Product manufacture
     to specifications.

11.  Notices
     -------

     Any notice or other communication required or permitted to be given by
     either party pursuant to the terms of this Agreement shall be in writing
     and shall be deemed given if

                                       5
<PAGE>

     and when delivered by hand or sent by certified mail, return receipt
     requested, overnight courier, confirmed telecopy, or confirmed electronic
     mail transmission, addressed as follows:

          If to Millipore:         Millipore Corporation
                                   80 Ashby Road
                                   Bedford, MA 01730
                                   Attn: Vice President, Manufacturing
                                         -----------------------------
                                   Fax: [(781)__________]

          with a copy to:          Millipore Corporation
                                   80 Ashby Road
                                   Bedford, MA 01730
                                   Attn:  General Counsel
                                   Fax:  (781) 533-3125

          If to Mykrolis:          Mykrolis Corporation
                                   Patriots Park
                                   Bedford, MA 01730
                                   Attn: Vice President, Manufacturing
                                         -----------------------------
                                   Fax:  [(781) ________]

          with a copy to:          Mykrolis Corporation
                                   Patriots Park
                                   Bedford, MA 01730
                                   Attn:  General Counsel
                                   Fax:  (781) _________

     or to such electronic mail address as may be specified by an addressee
     party to the other party by one of the other means provided above, or to
     such other address, telecopy number or electronic mail address as may be
     specified by an addressee party to the other by one of the means provided
     above.

12.  Force Majeure
     -------------

     The obligations of a party under this Agreement will be suspended to the
     extent that it is wholly or partially precluded from complying with its
     obligations under this Agreement by force majeure. Force majeure includes,
     but is not restricted to, fire, storm, flood, earthquake, explosion,
     accident, act of the public enemy, war, rebellion, insurrection, sabotage,
     epidemic, quarantine restriction, labor dispute, labor shortage,
     transportation embargo or failure or delay in transportation, act of God,
     act (including

                                       6
<PAGE>

     laws, regulations, disapprovals or failure to approve) of any government
     agency, whether national, municipal, or otherwise. The parties shall be
     relieved of their respective obligations hereunder, to the extent that the
     performance of such obligation was actually prevented thereby. During the
     existence of any such condition, the affected party shall, nevertheless,
     use its best efforts to remove the cause thereof.

13.  No Other Rights
     ---------------

     Neither party shall have any rights hereunder to any patents or other
     intellectual property of the other party, except as specifically set forth
     herein.

14.  Incorporation of Provisions from Master Agreement
     -------------------------------------------------

     The following provisions of the Master Agreement, mutatis mutandis, are
                                                       ------- --------
     hereby incorporated by reference into this Agreement for all purposes:

          Article VI (Confidentiality);
          Article IX (Dispute Resolution);
          Section 10.3 (Governing Law);
          Section 10.6 (Counterparts);
          Section 10.7 (Binding Effect; Assignment);
          Section 10.8 (Severability);
          Section 10.9 (Failure or Indulgence Not Waiver;
                          Remedies Cumulative);
          Section 10.10 (Amendment);
          Section 10.11 (Authority);
          Section 10.12 (Interpretation).

     In the event of any conflict between any of the foregoing incorporated
     provisions of the Master Agreement and any other provision of this
     Agreement, such other provisions shall prevail.

15.  Entire Agreement
     ----------------

     This Agreement, including Exhibit A attached hereto, is the entire
                               ------- -
     agreement between the parties with respect to the subject matter hereof,
     and supersedes any prior negotiations and agreements or understandings and
     any contemporaneous oral agreements or understandings with respect to the
     subject matter hereof.

                                       7
<PAGE>

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed by their duly authorized representatives effective as of the date first
set forth above.

MILLIPORE CORPORATION                 MYKROLIS CORPORATION

By: /s/ Francis J. Lunger             By: /s/ Jean-Marc Pandraud
    -----------------------------        -------------------------

Name: Francis J. Lunger               Name: Jean-Marc Pandraud
      ---------------------------          ------------------------

Title: Executive Vice President       Title: President
      ---------------------------           -----------------------

                                       8
<PAGE>

                         EXHIBIT A:  Product and Prices

Product:          Subassembly from Yonezawa MiE Manufacturing Plant for Molsheim
                  Labwater:

                  10176J       MICROGARD MINI/C D HP  1/4" 0.1

Iniital Pricing:  Mykrolis Standard Cost as of the effective date of this
                  Agreement as set forth in Mykrolis Oracle System, plus ten
                  percent of such standard cost.

                                       9<PAGE>

                                                                   Exhibit 10.23

                              Mykrolis Corporation
                                 Patriots Park
                               Bedford, MA  01730

                                SEPARATION NOTE

                             Due:  IPO Closing Date
        (as defined in the Master Separation and Distribution Agreement,
                          dated as of March 28, 2001)

$____________________                                       ______________, 2001

          On the fifteenth (15/th/) business day following the IPO Closing Date,
FOR VALUE RECEIVED, Mykrolis Corporation, a Delaware corporation (the
"Company"), hereby promises to pay to Millipore Corporation, a Massachusetts
corporation ("Payee") OR ORDER the principal sum in the amount equal to the net
proceeds to the Company from the IPO less the sum of: (i) the outstanding
                                     ----
balance under the Separation Revolving Credit Agreement plus (ii) all expenses
                                                        ----
related to the IPO plus (iii) _____________ Dollars. After maturity the Company
                   ----
shall pay interest on the unpaid principal amount hereof from the date of
maturity at a rate equal to the Base Rate (as defined below) plus 1.5%. Interest
shall be payable on demand. As used herein the term "Base Rate" shall mean the
base rate of interest charged on corporate loans posted by at least seventy-five
percent (75%) of the nation's thirty (30) largest banks, as from time to time
reported as the "Prime Rate" by The Wall Street Journal; changes in the Base
                                -----------------------
Rate shall be effective on the first business day of each calendar quarter.
Payment of principal, interest and all sums payable under (S)7 hereof shall be
payable at the principal office of the Payee. The payment of principal and
interest payable hereunder and the payment of all sums payable under (S)7 hereof
shall be made without necessity of presentation hereof by check or wire
transfer, drawn in immediately available funds, payable to the order of the
holder hereof. Capitalized terms used herein without definition shall have the
meaning ascribed thereto in the Master Separation and Distribution Agreement,
dated as of March 28, 2001.

          (S)1  Application of Payments.  Any payment of the indebtedness
                ------------------------
evidenced by this Note shall be applied (i) first, to the payment of the
interest accrued hereunder to the date of payment, (ii) then, to the payment of
all (if any) costs and expenses due and payable under (S)7 hereof on the date of
payment, and (iii) finally, to the payment of the unpaid principal of this Note.

          (S)2  Certain Affirmative Covenants of the Company.  The Company
                ---------------------------------------------
covenants and agrees that for so long as this Note is outstanding and unpaid
either as to the principal hereof or as to interest hereon, it will comply with
the following:

           (S)2.1  Punctual Payment.  The Company will duly and punctually pay
                   -----------------
all principal and interest hereunder, and all amounts payable pursuant to (S)7
below strictly in accordance with the terms and conditions of this Note.
<PAGE>

                                     --2--

           (S)2.2  Corporate Existence.  Maintain the Company's valid existence
                   --------------------
as a corporation under the laws of the State of Delaware;

           (S)2.3  Compliance.  Comply with the Company's Certificate of
                   ----------
Incorporation and with the Delaware Business Corporation Act; comply with all
other laws, governmental regulations, rules and ordinances, and will all
judicial orders, judgments and decrees applicable to the Company, its business
or its properties (except while the Company is in good faith by appropriate
proceedings contesting the validity of any of the foregoing); and keep adequate
and proper records and books of account in accordance with generally accepted
accounting principles consistently maintained (except as the Company shall
decide to make any change in accounting methods or practices which is consistent
with generally accepted accounting principles);

           (S)2.4  Taxes.  Punctually pay and discharge or cause to be paid and
                   -----
discharged all taxes, assessments and governmental charges lawfully imposed upon
the Company or any of its property, or upon any of its income, revenues or
profits; provided, however, that nothing contained in this (S)2.4 shall require
         --------  -------
the Company to pay or discharge any tax, assessment or governmental charge so
long as the Company shall be contesting the validity thereof in good faith by
appropriate proceedings and shall have set aside on its books adequate reserves
with respect thereto (segregated to the extent required by generally accepted
accounting principles);

           (S)2.5  Maintain Properties.  At all times maintain, preserve and
                   -------------------
keep the Company's properties and assets in such repair, working order and
condition that the business carried on by the Company in connection therewith
may be properly and advantageously conducted.

           (S)3    Negative Covenants of the Company.  The Company covenants and
                   ----------------------------------
agrees that for so long as this Note is outstanding and unpaid either as to the
principal hereof or as to interest hereon, the Company will not (unless the
holder of this Note shall have otherwise expressly consented thereto in
writing):

           (S)3.1  Liens, etc.  Create, assume or suffer to exist any mortgage,
                   ----------
pledge, lien, charge or other encumbrance of any kind on any of the Company's
property, assets, income or revenues, except liens securing indebtedness of the
Company for borrowed money to any bank or trust company whether outstanding on
the date of this Note or thereafter created or incurred.

           (S)3.2  Merger or Sale.  Consolidate or merge with or into any other
                   --------------
corporation; or divide into two or more corporations; or sell, transfer or
otherwise dispose of all or substantially all of the Company's property, assets,
income or revenues.

           (S)4    Events of Default.  If any one or more of the following
                   -----------------
events (herein called "Events of Default") shall occur, that is to say:

           (S)4.1  Failure to Pay.  Any payment of principal or interest
                   --------------
required by this Note or any sums payable under (S)7 hereof shall not be paid by
the Company punctually when and as the same shall become due and payable;
<PAGE>

                                     --3--

           (S)4.2  Performance of Obligations.  The Company shall fail to
                   --------------------------
perform, comply with or observe, or shall otherwise breach, any of the
affirmative covenants set forth in Section 2 above or of the negative covenants
set forth in Section 3 above or any other covenant, agreement or condition
contained herein and such failure or breach shall have continued for more than
thirty (30) days after the date on which the Company shall have first become
aware of such failure or breach;

           (S)4.4  Bankruptcy, Insolvency, etc.  The Company shall be
                   ---------------------------
adjudicated a bankrupt or insolvent; a petition for proceedings in bankruptcy or
liquidation or for the reorganization or the readjustment of the indebtedness of
the Company under applicable bankruptcy or insolvency laws now or hereafter
existing shall be filed against the Company and the Company shall admit the
material allegations thereof; an order, judgment or decree shall be made
approving any such petition, and such order, judgment or decree shall not be
vacated, set aside or stayed within sixty (60) days after its entry; or any
receiver, administrator, liquidator or trustee shall be appointed for the
Company or for all or any part of the property of the Company, and such
receiver, administrator, liquidator or trustee shall not be discharged or his
jurisdiction shall not be relinquished, vacated or stayed, on appeal or
otherwise, within sixty (60) days after his appointment;

then in any such case, the holder of this Note may, by giving notice to the
Company, declare the entire unpaid principal amount of this Note, all of the
unpaid interest accrued hereunder and all (if any) sums payable under (S) 7
hereof to be immediately due and payable, and thereupon, all of such principal,
interest and other sums shall forthwith become and be immediately due and
payable by the Company without presentment, demand, protest, any further notice
or any other formalities of any kind, all of which are hereby expressly waived
by the Company.

          (S)5  Waivers.  No failure or delay on the part of the holder of this
                --------
Note in exercising any right, remedy, power or privilege hereunder shall operate
as a waiver thereof nor shall any single or partial exercise thereof preclude
any other or further exercise of any such right, remedy, power or privilege or
of any other right, remedy, power or privilege of the holder of this Note
hereunder.

          (S)6  Holder.  The Company and all other persons may treat the last
                -------
holder of this Note of whom the Company shall have received written notice as
the original holder hereof for the purpose of receiving payment of the principal
of and the interest on this Note and for all other purposes and the Company, and
every successive holder of this Note, by accepting or holding the same, consents
to and agrees with the provisions of this Note.

          (S)7  Enforcement and Collection Costs, Etc.  In the event this Note
                --------------------------------------
shall be placed in the hands of attorneys for the enforcement of any covenant,
agreement or obligation set forth herein, the Company absolutely and
unconditionally agrees to pay to the holder of this Note on demand, in addition
to principal, interest and all other sums payable under or in respect of this
Note or the indebtedness evidenced hereby, all costs and expenses of enforcement
or collection, including all reasonable attorney's fees, incurred or sustained
by or on behalf of the holder of this Note.
<PAGE>

                                     --4--

          (S)8  Law Governing.  This Note is being executed and delivered in the
                --------------
Commonwealth of Massachusetts and shall be construed in accordance with and
governed by the laws of the Commonwealth of Massachusetts.

          (S)9  Severability, Etc.  It is hereby expressly agreed by the
                -----------------
Company and the holder hereof that nothing herein contained shall be so
construed as to require the Company to pay interest at a rate which is greater
than the rate for which it is now lawful to contract or to require the Company
to make any payment or do any other act contrary to law. In case any one or more
of the provisions contained in this Note shall be invalid, illegal or
unenforceable in any respect under any law applicable thereto, the validity,
legality and enforceability of the remaining provisions contained herein shall
not in any way be affected or impaired thereby.

          (S)10 Notices, Etc.   All notices, requests, consents and other
                ------------
communications hereunder shall be in writing, either delivered in hand or sent
by first-class mail, postage prepaid, or by telex, addressed as follows:

  (i)  if to the Company, at         Patriots Park
                                     Bedford, MA 01730; or

  (ii) if to Payee at:               80 Ashby Road
                                     Bedford, Massachusetts 01730.

The Company and every endorser or guarantor of this Note or the obligations
represented hereby waive presentment, demand, notice, protest, notice of intent
to accelerate, notice of acceleration, and all other demands and notices in
connection with the delivery, acceptance, performance, default or enforcement of
this Note, assent to any extension or postponement of the time of payment or any
other indulgence, to any substitution, exchange or release of collateral and to
the addition or release of any other party or person primarily or secondarily
liable on this Note or the obligations represented hereby.

      IN WITNESS WHEREOF, the said Mykrolis Corporation, a Delaware Corporation,
has caused this Note to be signed by its duly authorized officer.

      Dated:  ____________, 2001             Mykrolis Corporation

                                             By:
                                                --------------------------
                                                 Name:
                                                 Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}]]